SOX10
Transcription factor SOX-10
Also known as: DOM, SOX-10, SOX10_HUMAN, WS2E, WS4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56693
- Gene
- SOX10
- Ensembl
- ENSG00000100146
- Chromosome
- 22
- Canonical length
- 466 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein may act as a transcriptional activator after forming a protein complex with other proteins. This protein acts as a nucleocytoplasmic shuttle protein and is important for neural crest and peripheral nervous system development. Mutations in this gene are associated with Waardenburg-Shah and Waardenburg-Hirschsprung disease. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
466 residues, UniProt reviewed canonical sequence.
>P56693|SOX10
1 MAEEQDLSEV ELSPVGSEEP RCLSPGSAPS LGPDGGGGGS GLRASPGPGE LGKVKKEQQD
61 GEADDDKFPV CIREAVSQVL SGYDWTLVPM PVRVNGASKS KPHVKRPMNA FMVWAQAARR
121 KLADQYPHLH NAELSKTLGK LWRLLNESDK RPFIEEAERL RMQHKKDHPD YKYQPRRRKN
181 GKAAQGEAEC PGGEAEQGGT AAIQAHYKSA HLDHRHPGEG SPMSDGNPEH PSGQSHGPPT
241 PPTTPKTELQ SGKADPKRDG RSMGEGGKPH IDFGNVDIGE ISHEVMSNME TFDVAELDQY
301 LPPNGHPGHV SSYSAAGYGL GSALAVASGH SAWISKPPGV ALPTVSPPGV DAKAQVKTET
361 AGPQGPPHYT DQPSTSQIAY TSLSLPHYGS AFPSISRPQF DYSDHQPSGP YYGHSGQASG
421 LYSAFSYMGP SQRPLYTAIS DPSPSGPQSH SPTHWEQPVY TTLSRPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SOX10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 152 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 152 nTPM
- salivary gland: 105 nTPM
- hippocampal formation: 83 nTPM
- midbrain: 80 nTPM
- amygdala: 63 nTPM
- basal ganglia: 62 nTPM
Single-cell type
- schwann cells: 184 nCPM
- melanocytes: 168 nCPM
- oligodendrocytes: 135 nCPM
- oligodendrocyte progenitor cells: 130 nCPM
- lacrimal acinar cells: 96 nCPM
- breast lactating cells: 87 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 329 nTPM
- medulla oblongata: 229 nTPM
- basal ganglia: 222 nTPM
- cerebral cortex: 187 nTPM
- midbrain: 185 nTPM
- thalamus: 182 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SOX10.
Disease | AllUniProt
Conditions SOX10 is implicated in, by any mechanism.
- Waardenburg syndrome 2E (WS2E) MIM:611584
- Waardenburg syndrome 4C (WS4C) MIM:613266
- Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) MIM:609136
Disease | GeneticClinVar
233 pathogenic / likely-pathogenic of 575 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Waardenburg syndrome type 4C
- Waardenburg syndrome type 2E
- PCWH syndrome
- SOX10-related disorder
- Waardenburg syndrome type 2E, without neurologic involvement
Disease | ImmuneIEDB
Conditions an epitope on SOX10 was assayed in.
- melanoma T cell
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.21
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 2.77
- DepMap mean gene effect
- -0.29
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure morphogenesis
- cell maturation
- cellular response to progesterone stimulus
- cellular response to xenobiotic stimulus
- central nervous system myelination
- developmental growth
- digestive tract morphogenesis
- enteric nervous system development
- in utero embryonic development
- lacrimal gland development
- melanocyte differentiation
- morphogenesis of a branching epithelium
- morphogenesis of an epithelium
- negative regulation of apoptotic process
- negative regulation of canonical Wnt signaling pathway
- negative regulation of Schwann cell proliferation
- negative regulation of transcription by RNA polymerase II
- neural crest cell migration
- neuroblast proliferation
- oligodendrocyte development
- oligodendrocyte differentiation
- peripheral nervous system development
- positive regulation of DNA-templated transcription
- positive regulation of gene expression
- positive regulation of gliogenesis
- positive regulation of myelination
- positive regulation of neuroblast proliferation
- regulation of transcription by RNA polymerase II
- transcription elongation by RNA polymerase II
Molecular functions
- DNA binding
- DNA-binding transcription activator activity
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor binding
- identical protein binding
- promoter-specific chromatin binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SOX10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SOX10 as an antibody target. Whether an autoantibody or antibody against SOX10 could matter depends on whether native SOX10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SOX10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SOX10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...